COHERENT, INC. 
By SANTA CLARA, Calif., Jan. 28 /PRNewswire-FirstCall/ -- Coherent, Inc. (Nasdaq: COHR), a world leader in providing photonics based solutions to the commercial and scientific research markets, today announced financial results for its first fiscal quarter ended January 2, 2010.
FINANCIAL HIGHLIGHTS
Three Months Ended
------------------
GAAP Results January 2, October 3, December 27,
(in millions except per
share data) 2010 2009 2008
---- ---- ----
Bookings $158.4 $133.4 $103.3
Net sales $122.8 $107.6 $124.4
Net income (loss) $4.2 $(4.5) $(14.7)
Diluted EPS $0.17 $(0.18) $(0.61)
Non-GAAP Results
(in millions except per share data)
Net income (loss) $5.1 $(0.9) $8.6
Diluted EPS $0.21 $(0.04) $0.36
FIRST FISCAL QUARTER DETAILS
For the first fiscal quarter ended January 2, 2010, Coherent announced net sales of $122.8 million and net income, on a U.S. generally accepted accounting principles (GAAP) basis, of $4.2 million ($0.17 per diluted share). These results compare to net sales of $124.4 million and net loss of $14.7 million, or $0.61 per share, for the first quarter of fiscal 2009. Non-GAAP net income for the first quarter of fiscal 2010 was $5.1 million or $0.21 per diluted share and non-GAAP net income for the first quarter of fiscal 2009 was $8.6 million, or $0.36 per diluted share. Please see the reconciliation of GAAP to non-GAAP results included on the last page of our release.
Net sales for the fourth quarter of fiscal 2009 were $107.6 million and net loss, on a GAAP basis, was $4.5 million ($0.18 per share). Non-GAAP net loss for the fourth quarter of fiscal 2009 was $0.9 million or $0.04 per share.
Bookings received during the three months ended January 2, 2010 of $158.4 million increased 53.3% from $103.3 million in the same prior year period and increased by 18.7% compared to bookings of $133.4 million in the immediately preceding quarter. The book-to-bill ratio was 1.3, resulting in backlog of $202.8 million at January 2, 2010 compared to a backlog of $164.3 million at October 3, 2009 and a backlog of $162.0 million at December 27, 2008.
We ended the quarter with cash and short term investments of $240.6 million, a decrease of $3.0 million from cash and short term investments of $243.6 million at October 3, 2009. The decrease includes $15.0 million spent to acquire certain assets of StockerYale, Inc.
"There were a number of positive takeaways from the first quarter, including increasing sales, a return to profitability, good cash generation and very healthy bookings. Orders were up significantly over the prior year period in all four markets. We are particularly pleased with orders of approximately $22 million for our Coherent Equinox(TM) solar production tools, which are scheduled for delivery during fiscal 2010," said John Ambroseo, Coherent's President and Chief Executive Officer. "Given our backlog and outlook, we are raising our fiscal 2010 projection for net sales to $525 to $550 million. To achieve this targeted range, we are ramping production capacity and unwinding the temporary cost containment measures implemented during fiscal 2009," he added.
"I am also pleased to report that we are making good progress on our product initiatives. The customer qualifications of the DIAMOND(TM) E-1000 sealed CO2 laser is progressing as planned and we will begin revenue shipments in our third fiscal quarter. We have further enhanced our scientific product portfolio with high performance devices to address new applications in physics and chemistry. We also continue to proliferate our OPSL platform with the introduction of the Verdi(TM) G7, which supports a number of applications in the research market, as well as wavelength extensions of the Genesis(TM) series for use in the OEM components and instrumentation market," Ambroseo said.
BUSINESS OUTLOOK
With the strong customer order demand Coherent experienced in its first fiscal quarter, the Company announced that it expects sales in its second fiscal quarter to be in the range of $135 to $140 million. Additionally, with the combination of key customer wins in solar and a market recovery, the Company is raising its fiscal 2010 guidance for net sales to a range of $525 to $550 million.
CONFERENCE CALL REMINDER
The Company will host a conference call today to discuss its financial results at 1:30 P.M. Pacific (4:30 P.M. Eastern). A listen-only broadcast of the conference call can be accessed on the Company's website at either http://www.coherent.com/Investors/ or http://www.earnings.com. For those who are not available to listen to the live broadcast, the call will be archived for approximately three months on both web sites. A transcript of management's prepared remarks can be found at http://www.coherent.com/Investors/.
Summarized statement of operations information is as follows (unaudited, in thousands except per share data):
Three Months Ended
------------------
January 2, October 3, December 27,
2010 2009 2008
---- ---- ----
Net sales $122,815 $107,593 $124,388
Cost of sales (A)(B)(E) 71,783 70,093 73,999
------ ------ ------
Gross profit 51,032 37,500 50,389
Operating expenses:
Research & development (A)(B)(E) 15,410 15,500 14,778
Selling, general & administrative
(A)(B)(C)(E) 27,979 27,285 23,628
Impairment of goodwill(D) - - 19,286
Intangibles amortization 1,961 1,722 1,943
----- ----- -----
Total operating expenses 45,350 44,507 59,635
------ ------ ------
Income (loss) from operations 5,682 (7,007) (9,246)
Other income (expense), net(E) 792 1,803 (4,230)
--- ----- ------
Income (loss) before income taxes 6,474 (5,204) (13,476)
Provision (benefit) for income
taxes(F) 2,295 (709) 1,203
----- ---- -----
Net income (loss) $4,179 $(4,495) (14,679)
====== ======= =======
Net income (loss) per share:
Basic $0.17 $(0.18) $(0.61)
===== ====== ======
Diluted $0.17 $(0.18) $(0.61)
===== ====== ======
Shares used in computation:
Basic 24,469 24,390 24,145
====== ====== ======
Diluted 24,678 24,390 24,145
====== ====== ======
(A) Stock-related compensation expense included in operating results is summarized below (all footnote amounts are unaudited, in thousands):
Stock-related compensation expense Three Months Ended
------------------
January 2, October 3, December 27,
2010 2009 2008
---- ---- ----
Cost of sales $219 $93 $283
Research & development 273 250 195
Selling, general &
administrative 1,670 940 1,212
----- --- -----
Impact on income (loss) from
operations $2,162 $1,283 $1,690
------ ------ ------
For the quarters ended January 2, 2010, October 3, 2009 and December 27, 2008, the impact on net income (loss), net of tax was $1,519 ($0.06 per diluted share), $1,308 ($0.05 per share) and $1,153 ($0.05 per diluted share), respectively.
(B) Restructuring costs included in operating results are summarized below:
Restructuring costs Three Months Ended
------------------
January 2, October 3, December 27,
2010 2009 2008
---- ---- ----
Cost of sales $309 $743 $3,022
Research & development 409 519 466
Selling, general &
administrative 518 412 618
--- --- ---
Impact on income (loss)
from operations $1,236 $1,674 $4,106
------ ------ ------
For the quarters ended January 2, 2010, October 3, 2009, December 27, 2008, the impact on net income (loss), net of tax was $813 ($0.03 per diluted share), $1,054 ($0.04 per share), and $2,613 ($0.11 per diluted share), respectively.
(C) The quarter ended January 2, 2010 includes a $2,185 ($1,438 net of tax ($0.06 per diluted share)) net receipt from the settlement of litigation resulting from our internal stock option investigation. The quarter ended October 3, 2009 includes $192 ($121 net of tax ($0.00 per share)) of costs related to litigation resulting from our internal stock option investigation. The quarter ended December 27, 2008 includes $441 ($269 net of tax ($0.01 per diluted share)) of costs related to litigation resulting from our internal stock option investigation.
(D) The quarter ended December 27, 2008 includes a $19,286 ($0.80 per diluted share) non-cash charge for the impairment of all of the goodwill of our Commercial Lasers and Components segment.
(E) Changes in deferred compensation plan liabilities are included in cost of sales and operating expenses while gains and losses on deferred compensation plan assets are included in other income (expense) net. Deferred compensation expense (benefit) included in operating results is summarized below:
Deferred compensation expense
(benefit) Three Months Ended
------------------
January 2, October 3, December 27,
2010 2009 2008
---- ---- ----
Cost of sales $32 $43 $(174)
Research & development 132 182 (988)
Selling, general &
administrative 1,114 1,476 (5,784)
----- ----- ------
Impact on income (loss)
from operations $1,278 $1,701 $(6,946)
------ ------ -------
For the quarters ended January 2, 2010, October 3, 2009 and December 27, 2008, the impact on other income (expense) net from gains or losses on deferred compensation plan assets was income of $1,063, income of $1,435 and expense of $6,798, respectively.
(F) The quarter ended October 3, 2009 includes a $1,111 ($0.05 per share) increase in valuation allowances against deferred tax assets.
Summarized balance sheet information is as follows (unaudited, in thousands):
January 2, October 3,
2010 2009
----------- ----------
ASSETS
Current assets:
Cash, cash equivalents and short-term
investments $240,626 $243,635
Accounts receivable, net 76,136 74,235
Inventories 98,924 97,767
Prepaid expenses and other assets 70,775 67,133
------ ------
Total current assets 486,461 482,770
Property and equipment, net 100,062 98,792
Other assets 184,182 172,042
------- -------
Total assets $770,705 $753,604
======== ========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Current portion of long-term obligations $21 $9
Accounts payable 24,359 21,639
Other current liabilities 73,528 64,694
------ ------
Total current liabilities 97,908 86,342
Other long-term liabilities 92,098 91,691
Total stockholders' equity 580,699 575,571
------- -------
Total liabilities and stockholders' equity $770,705 $753,604
======== ========
Reconciliation of GAAP to Non-GAAP net income (unaudited, in thousands, net of tax):
Three Months Ended
January 2, October 3, December 27,
2010 2009 2008
----------- ---------- -------------
GAAP net income (loss) $4,179 $(4,495) $(14,679)
Stock option
investigation and
litigation expense
(benefit) (1,438) 121 269
Stock-related
compensation expense 1,519 1,308 1,153
Impairment of goodwill -- -- 19,286
Restructuring costs 813 1,054 2,613
One-time tax expense -- 1,111 --
--- ----- ---
Non-GAAP net income
(loss) $5,073 $(901) $8,642
====== ===== ======
Non-GAAP net income
per share (loss) $0.21 $(0.04) $0.36
===== ====== =====
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements, as defined under the Federal securities laws. These forward-looking statements include the statements in this press release that relate to fiscal 2010 annual sales guidance and second fiscal quarter sales guidance, scheduled delivery dates for the Company's products, customer qualifications of the Company's products, and the timing of shipments for the Company's products. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause our actual results to differ materially and adversely from those expressed in any forward-looking statement. Factors that could cause actual results to differ materially include risks and uncertainties, including, but not limited to, risks associated with quarterly and annual fluctuations in our net sales and operating results, our and our customers' exposure to risks associated with worldwide economic slowdowns, the ability of our customers to forecast their own end markets, our ability to increase our sales volumes, our ability to accurately forecast future periods, the impact that our operations and potential acquisitions will have on net sales, customer acceptance and adoption of our new product offerings and continued purchases of our existing products and services, our ability to timely ship our products and our customers' ability to accept such shipments, our ability to have our customers qualify our product offerings, and other risks identified in the Company's SEC filings. Readers are encouraged to refer to the risk disclosures described in the Company's reports on Forms 10-K, 10-Q and 8-K, as applicable and as filed from time-to-time by the Company. Actual results, events and performance may differ materially from those presented herein. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update these forward-looking statements as a result of events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets and part of the Russell 2000. Please direct any questions to Leen Simonet, Chief Financial Officer at 408-764-4161. For more information about Coherent, visit the Company's Web site at http://www.coherent.com/ for product and financial updates.
SOURCE Coherent, Inc.
